Get the Stockscreener App
33.92
1.22%
0.41
Korsana Biosciences, Inc. Common Stock Stock (KRSA) Forecast
The Korsana Biosciences, Inc. Common Stock (KRSA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $32.29, representing a -4.81% decrease from the current price of $33.92. The highest analyst price target is $39.55, and the lowest is $25.03.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month KRSA Price Target
Average 40.41
(+19.12% Upside)
Is Korsana Biosciences, Inc. Common Stock (KRSA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 60.41 | Neutral |
| STOCH(9,6) | 37.01 | Neutral |
| STOCHRSI(14) | 0.00 | Neutral |
| MACD(12,26) | 0.00 | Neutral |
| ADX(14) | 0.00 | Neutral |
| William %R | -40.62 | Neutral |
| CCI(14) | 35.08 | Neutral |
Buy: 0
Sell: 0
Neutral: 7
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
32.01
Buy
|
32.34
Buy
|
| MA20 |
32.62
Buy
|
32.14
Buy
|
| MA50 |
14.70
Buy
|
0.00
Buy
|
| MA100 |
7.3507
Buy
|
0.00
Buy
|
| MA200 |
3.6753
Buy
|
0.00
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, KRSA could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 0 signaling Sell signals and 7 Neutral signals. This might be a good time to open fresh positions on KRSA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 60.41 indicates that KRSA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 37.01 indicates that KRSA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0 indicates that KRSA is oversold. This suggests that KRSA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 0 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 35.08 indicates that KRSA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term KRSA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Korsana Biosciences, Inc. Common Stock financial reports and earnings history, Korsana Biosciences, Inc. Common Stock (KRSA) stock could reach $97.05 by 2030, $277.89 by 2040 and $458.91 by 2050. See the projected annual prices until 2050 of the Korsana Biosciences, Inc. Common Stock stock below:
- Korsana Biosciences, Inc. Common Stock (KRSA) is expected to reach an average price of $183.63 in 2035, with a high prediction of $188.06 and a low estimate of $168.10. This indicates an $441.37% rise from the last recorded price of $33.92.
- Korsana Biosciences, Inc. Common Stock (KRSA) stock is projected to chart a bullish course in 2040, with an average price target of $274.07, representing an $707.99% surge from its current level. The forecast ranges from a conservative $254.74 to a sky-high $277.89.
- Our analysts predict Korsana Biosciences, Inc. Common Stock (KRSA) to jump 963.63% by 2045, soaring from $343.40 to an average price of $360.78, potentially reaching $372.59. While $343.40 is the low estimate, the potential upside is significant.
- Korsana Biosciences, Inc. Common Stock (KRSA) stock is expected to climb by 2050, reaching an average of $456.76, a $1,247% jump from its current level. However, a wide range of estimates exists, with high and low targets of $458.91 and $430.05, respectively, highlighting the market's uncertainty.
Korsana Biosciences, Inc. Common Stock Stock (KRSA) Year by Year Forecast
Korsana Biosciences, Inc. Common Stock Stock (KRSA) Price Forecast for 2026
The predicted value for Korsana Biosciences, Inc. Common Stock (KRSA) in 2026 is set at an average of $31.19. Estimates vary from a peak of $41.38 to a trough of $21.00, indicating an -8.05% surge from the present price of $33.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $39.06 | $25.03 | $39.55 | +15.16% |
| December, 2026 | $38.16 | $33.19 | $41.38 | +12.51% |
Korsana Biosciences, Inc. Common Stock Stock (KRSA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Korsana Biosciences, Inc. Common Stock (KRSA) is $43.47, with a high forecast of $59.90 and a low forecast of $27.05. This indicates an +28.16% increase from the last price of $33.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $38.24 | $27.05 | $43.44 | +12.72% |
| February, 2027 | $43.13 | $29.06 | $43.62 | +27.17% |
| March, 2027 | $41.98 | $31.08 | $45.49 | +23.76% |
| April, 2027 | $40.99 | $39.42 | $47.55 | +20.84% |
| May, 2027 | $44.47 | $33.09 | $49.61 | +31.11% |
| June, 2027 | $49.24 | $35.11 | $49.73 | +45.18% |
| July, 2027 | $48.77 | $43.58 | $51.67 | +43.77% |
| August, 2027 | $47.29 | $37.12 | $53.72 | +39.41% |
| September, 2027 | $49.52 | $39.14 | $55.78 | +45.98% |
| October, 2027 | $52.06 | $41.15 | $55.48 | +53.46% |
| November, 2027 | $55.13 | $49.74 | $57.84 | +62.53% |
| December, 2027 | $54.86 | $43.17 | $59.90 | +61.75% |
Korsana Biosciences, Inc. Common Stock Stock (KRSA) Price Forecast for 2028
In 2028, Korsana Biosciences, Inc. Common Stock (KRSA) is projected to reach an average price of $60.77, with a high projection of $76.36 and a low estimate of $45.18. This indicates an +79.15% rise from the last price of $33.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $55.69 | $45.18 | $61.95 | +64.18% |
| February, 2028 | $58.10 | $47.20 | $61.71 | +71.29% |
| March, 2028 | $57.79 | $55.85 | $64.01 | +70.37% |
| April, 2028 | $59.80 | $49.21 | $66.07 | +76.31% |
| May, 2028 | $65.53 | $51.23 | $66.02 | +93.20% |
| June, 2028 | $65.74 | $60.21 | $68.13 | +93.80% |
| July, 2028 | $64.09 | $53.24 | $70.18 | +88.94% |
| August, 2028 | $65.98 | $55.26 | $72.24 | +94.51% |
| September, 2028 | $68.18 | $57.27 | $72.11 | +100.99% |
| October, 2028 | $72.10 | $66.03 | $74.30 | +112.56% |
| November, 2028 | $71.49 | $59.29 | $76.36 | +110.77% |
| December, 2028 | $75.71 | $61.30 | $76.20 | +123.21% |
Korsana Biosciences, Inc. Common Stock Stock (KRSA) Price Forecast for 2029
The 2029 price forecast for Korsana Biosciences, Inc. Common Stock Stock (KRSA) is $79.14 on average, with a high prediction of $94.97 and a low estimate of $63.32. This represents an +133.32% increase from the previous price of $33.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $74.22 | $63.32 | $78.41 | +118.81% |
| February, 2029 | $74.59 | $72.14 | $80.47 | +119.89% |
| March, 2029 | $76.26 | $65.33 | $82.53 | +124.83% |
| April, 2029 | $81.82 | $67.35 | $82.50 | +141.22% |
| May, 2029 | $82.70 | $76.84 | $84.59 | +143.82% |
| June, 2029 | $81.89 | $69.36 | $86.66 | +141.41% |
| July, 2029 | $82.44 | $71.38 | $88.70 | +143.03% |
| August, 2029 | $84.30 | $73.39 | $88.74 | +148.51% |
| September, 2029 | $85.09 | $82.32 | $90.81 | +150.84% |
| October, 2029 | $88.12 | $75.41 | $92.89 | +159.80% |
| November, 2029 | $92.00 | $77.42 | $92.61 | +171.24% |
| December, 2029 | $90.34 | $79.44 | $94.97 | +166.33% |
Korsana Biosciences, Inc. Common Stock Stock (KRSA) Price Forecast for 2030
Korsana Biosciences, Inc. Common Stock Stock (KRSA) is expected to reach an average price of $97.56 in 2030, with a high forecast of $113.68 and a low forecast of $81.45. This signifies an +187.63% surge from the last price of $33.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $91.39 | $88.43 | $97.05 | +169.41% |
| February, 2030 | $92.72 | $81.45 | $98.99 | +173.36% |
| March, 2030 | $94.37 | $83.47 | $99.13 | +178.21% |
| April, 2030 | $99.67 | $92.50 | $101.21 | +193.85% |
| May, 2030 | $98.52 | $85.48 | $103.29 | +190.44% |
| June, 2030 | $102.18 | $87.50 | $103.21 | +201.25% |
| July, 2030 | $100.42 | $89.51 | $105.36 | +196.03% |
| August, 2030 | $101.88 | $98.61 | $107.44 | +200.37% |
| September, 2030 | $104.75 | $91.53 | $109.52 | +208.82% |
| October, 2030 | $108.29 | $93.54 | $109.58 | +219.26% |
| November, 2030 | $110.28 | $103.86 | $111.70 | +225.11% |
| December, 2030 | $108.18 | $95.56 | $113.68 | +218.94% |
1.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):